AZIN2
Basic information
Region (hg38): 1:33081104-33123492
Previous symbols: [ "ADC" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AZIN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 2 | 3 |
Variants in AZIN2
This is a list of pathogenic ClinVar variants found in the AZIN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-33082340-T-C | not specified | Uncertain significance (Aug 02, 2022) | ||
1-33084063-A-G | not specified | Uncertain significance (Feb 27, 2023) | ||
1-33092104-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
1-33092140-G-T | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
1-33092150-A-T | not specified | Uncertain significance (Mar 27, 2023) | ||
1-33092185-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
1-33092209-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
1-33092212-C-T | Benign (Dec 28, 2017) | |||
1-33093296-T-C | not specified | Uncertain significance (May 02, 2024) | ||
1-33093332-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
1-33093391-C-A | Benign (May 31, 2018) | |||
1-33094597-A-G | not specified | Uncertain significance (Dec 26, 2023) | ||
1-33094610-G-A | not specified | Uncertain significance (May 11, 2022) | ||
1-33094662-C-A | not specified | Uncertain significance (Dec 07, 2021) | ||
1-33096715-C-T | Benign (Dec 28, 2017) | |||
1-33096791-T-A | not specified | Uncertain significance (May 27, 2022) | ||
1-33096855-A-C | not specified | Uncertain significance (Mar 30, 2024) | ||
1-33098091-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
1-33098168-A-C | not specified | Uncertain significance (Sep 07, 2022) | ||
1-33117906-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
1-33117959-G-A | not specified | Uncertain significance (Jun 06, 2023) | ||
1-33118001-C-T | not specified | Uncertain significance (Jun 16, 2024) | ||
1-33118053-T-C | not specified | Likely benign (Dec 06, 2021) | ||
1-33118062-C-G | not specified | Uncertain significance (Jan 23, 2024) | ||
1-33118064-T-C | not specified | Likely benign (Oct 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AZIN2 | protein_coding | protein_coding | ENST00000294517 | 9 | 39427 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.87e-7 | 0.926 | 125709 | 0 | 39 | 125748 | 0.000155 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.467 | 246 | 267 | 0.920 | 0.0000147 | 3000 |
Missense in Polyphen | 69 | 91.555 | 0.75365 | 1068 | ||
Synonymous | 0.290 | 113 | 117 | 0.966 | 0.00000726 | 936 |
Loss of Function | 1.75 | 13 | 21.8 | 0.596 | 0.00000112 | 238 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.000233 | 0.000231 |
European (Non-Finnish) | 0.0000970 | 0.0000967 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000427 | 0.000425 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Antizyme inhibitor (AZI) protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake. AZI is an enzymatically inactive ODC homolog that counteracts the negative effect of ODC antizymes (AZs) OAZ1, OAZ2 and OAZ3 on ODC activity by competing with ODC for antizyme- binding (PubMed:17900240). Inhibits antizyme-dependent ODC degradation and releases ODC monomers from their inactive complex with antizymes, leading to formation of the catalytically active ODC homodimer and restoring polyamine production (PubMed:17900240). Participates in the morphological integrity of the trans-Golgi network (TGN) and functions as a regulator of intracellular secretory vesicle trafficking (PubMed:20188728). {ECO:0000269|PubMed:17900240, ECO:0000269|PubMed:20188728}.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);putrescine biosynthesis II;Agmatine biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.324
Intolerance Scores
- loftool
- rvis_EVS
- 0.0000761
- rvis_percentile_EVS
- 53.98
Haploinsufficiency Scores
- pHI
- 0.427
- hipred
- N
- hipred_score
- 0.354
- ghis
- 0.521
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Azin2
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- spermatogenesis;putrescine transport;putrescine biosynthetic process from ornithine;negative regulation of protein catabolic process;positive regulation of catalytic activity;agmatine biosynthetic process;trans-Golgi network membrane organization;positive regulation of polyamine transmembrane transport
- Cellular component
- nucleus;cytoplasm;mitochondrion;cis-Golgi network;trans-Golgi network;cytosol;transport vesicle;axon;dendrite;cytoplasmic vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;perikaryon;perinuclear region of cytoplasm;granular vesicle
- Molecular function
- ornithine decarboxylase activity;protein binding;arginine decarboxylase activity;putrescine transmembrane transporter activity;ornithine decarboxylase activator activity